Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
84.4M
-
Shares change
-
+12.2M
-
Total reported value, excl. options
-
$1.85B
-
Value change
-
+$298M
-
Put/Call ratio
-
1.43
-
Number of buys
-
112
-
Number of sells
-
-50
-
Price
-
$21.90
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2024
212 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q3 2024.
Summit Therapeutics Inc. - COM (SMMT) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.4M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (24.4M shares), VANGUARD GROUP INC (10.9M shares), FMR LLC (8.3M shares), BlackRock, Inc. (8.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.44M shares), STATE STREET CORP (3.47M shares), GEODE CAPITAL MANAGEMENT, LLC (3.1M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.43M shares), MILLENNIUM MANAGEMENT LLC (1.22M shares), and abrdn plc (1.14M shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.